The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Use of the Inactivated Intranasal Influenza Vaccine and the Risk of Bell's Palsy in Switzerland
Open accessAbstract
BACKGROUND: After the introduction of an inactivated intranasal influenza vaccine that was used only in Switzerland, 46 cases of Bell's palsy were reported. METHODS: We conducted a matched case-control study and a case-series analysis. All primary care physicians, ear, nose, and throat specialists, and neurologists in German-speaking regions of Switzerland were requested to identify cases of Bell's palsy diagnosed in adults between October 1, 2000, and April 30, 2001. Each physician was invited to select three control patients for each patient with Bell's palsy, with matching according to age, date of the clinic visit, and physician. Vaccination information was provided by the physicians. RESULTS: A total of 773 patients with Bell's palsy were identified. Of the 412 (53.3 percent) who could be evaluated, 250 (60.7 percent) were enrolled and matched with 722 control patients; the other 162 patients had no controls. In the case-control study, we found that 68 patients with Bell's palsy (27.2 percent) and 8 controls (1.1 percent) had received the intranasal vaccine (P<0.001). In contrast to parenteral vaccines, the intranasal vaccine significantly increased the risk of Bell's palsy (adjusted odds ratio, 84.0; 95 percent confidence interval, 20.1 to 351.9). Even according to conservative assumptions, the relative risk of Bell's palsy was estimated to be 19 times the risk in the controls, corresponding to 13 excess cases per 10,000 vaccinees within 1 to 91 days after vaccination. In the case-series analysis, the period of highest risk was 31 to 60 days after vaccination. CONCLUSIONS: This study suggests a strong association between the inactivated intranasal influenza vaccine used in Switzerland and Bell's palsy. This vaccine is no longer in clinical use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Belshe, R. B., Mendelman, P. M., Treanor, J., King, J., Gruber, W. C., Piedra, P., Bernstein, D. I., Hayden, F. G., Kotloff, K., Zangwill, K., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805143382002 · Cited by 916
Bell Palsy and Herpes Simplex Virus: Identification of Viral DNA in Endoneurial Fluid and Muscle
Murakami, S., Mizobuchi, M., Nakashiro, Y., Doi, T., Hato, N., & Yanagihara, N. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-1_part_1-199601010-00005 · Cited by 743
Relative Incidence Estimation from Case Series for Vaccine Safety Evaluation
Farrington, C. P. (1995) · Biometrics · doi:10.2307/2533328 · Cited by 367
Incidence, clinical features, and prognosis in Bell's palsy, Rochester, Minnesota, 1968–1982
Katusic, S. K., Beard, C. M., Wiederholt, W. C., Bergstralh, E. J., & Kurland, L. T. (1986) · Annals of Neurology · doi:10.1002/ana.410200511 · Cited by 356
Adour, K. K., Ruboyianes, J. M., Trent, C. S., Doersten, P. G. V., Quesenberry, C. P., Byl, F. M., & Hitchcock, T. (1996) · Annals of Otology Rhinology & Laryngology · doi:10.1177/000348949610500508 · Cited by 296
Deaths: leading causes for 2000.
Anderson, R. N. (2002) · PubMed · Cited by 283
The epidemiology and treatment of Bell’s palsy in the UK
Rowlands, S., Hooper, R., Hughes, R., & Burney, P. (2002) · European Journal of Neurology · doi:10.1046/j.1468-1331.2002.00343.x · Cited by 237
Case Series Analysis of Adverse Reactions to Vaccines: A Comparative Evaluation
Farrington, C. P., Nash, J., & Miller, E. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008695 · Cited by 235
A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants
Fujihashi, K., Koga, T., van Ginkel, F. W., Hagiwara, Y., & McGhee, J. R. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00155-x · Cited by 175
Manipulating the immune system: humoral versus cell-mediated immunity
McNeela, E. A., & Mills, K. H. G. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00169-7 · Cited by 106
Glück, R., Mischler, R., Durrer, P., Fürer, E., Lang, A. B., Herzog, C., & Cryz, S. J. (2000) · The Journal of Infectious Diseases · doi:10.1086/315337 · Cited by 101
Glueck, R. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00292-4 · Cited by 63
Review of intranasal influenza vaccine
Glueck, R. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00174-0 · Cited by 39
Valserra, M. D. B. D., Zanasi, A., Ragusa, S., Glück, R., & Herzog, C. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)85008-1 · Cited by 25
Cited by
Mucosal vaccines: the promise and the challenge
Neutra, M. R., & Kozlowski, P. A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1777 · Cited by 1,223
Nanotechnology: Intelligent Design to Treat Complex Disease
Couvreur, P., & Vauthier, C. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0284-8 · Cited by 948
Vaccines for preventing influenza in healthy adults
Jefferson, T., Di Pietrantonj, C., Rivetti, A., Bawazeer, G. A., Al-Ansary, L. A., & Ferroni, E. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001269.pub4 · Cited by 896
Recent progress in mucosal vaccine development: potential and limitations
Lycke, N. (2012) · Nature Reviews Immunology · doi:10.1038/nri3251 · Cited by 807
Early Treatment with Prednisolone or Acyclovir in Bell's Palsy
Sullivan, F. M., Swan, I. R. C., Donnan, P. T., Morrison, J. M., Smith, B. H., McKinstry, B., Davenport, R. J., Vale, L. D., Clarkson, J. E., Hammersley, V., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072006 · Cited by 771
Metadata
- Authors
- Mutsch, M., Zhou, W., Rhodes, P., Bopp, M., Chen, R. T., Linder, T., Spyr, C., & Steffen, R.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-02-26
- Volume
- 350
- Issue
- 9
- Pages
- 896-903
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2002392006
- Cited by
- 916
- References
- 14
- FWCI
- 26.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.